Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early appropriate diagnostics and treatment of MDR Gram-negative infections
Matteo Bassetti, Souha S. Kanj, Pattarachai Kiratisin, et al.
JAC-Antimicrobial Resistance (2022) Vol. 4, Iss. 5
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
André Bittencourt Lorusso, João Antônio Carrara, Carolina Deuttner Neumann Barroso, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15779-15779
Open Access | Times Cited: 139
Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence
Pierluigi Viale, Christian E. Sandrock, Paula Ramírez, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists
Eric Wenzler, Mira Maximos, Tomefa E. Asempa, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 4, pp. 264-278
Open Access | Times Cited: 22
Antimicrobial stewardship and molecular diagnostics: a symbiotic approach to combating resistance in the ED and ICU
Jan J. De Waele, Jerina Boelens
Current Opinion in Critical Care (2024) Vol. 30, Iss. 3, pp. 231-238
Closed Access | Times Cited: 5
Antimicrobial Resistance: Linking Molecular Mechanisms to Public Health Impact
Ghazala Muteeb, Raisa Nazir Ahmed Kazi, Mohammad Aatif, et al.
SLAS DISCOVERY (2025), pp. 100232-100232
Open Access
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients
Hélio S. Sader, Rodrigo E. Mendes, John H. Kimbrough, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 564-564
Open Access | Times Cited: 4
New Agents Are Coming, and So Is the Resistance
J. Myles Keck, Alina Viteri, Jacob Gammelgaard Schultz, et al.
Antibiotics (2024) Vol. 13, Iss. 7, pp. 648-648
Open Access | Times Cited: 4
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol
Gabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14132-14153
Open Access | Times Cited: 4
A Machine Learning and Neural Network Approach for Classifying Multidrug-Resistant Bacterial Infections
Preeda Mengsiri, Ratchadaporn Ungcharoen, Sethavidh Gertphol
Healthcare Analytics (2025), pp. 100388-100388
Open Access
Frequency, Antimicrobial Susceptibility, and Molecular Characterization of Carbapenem-Resistant Enterobacterales Stratified by United States Census Divisions: Results From the INFORM Program (2018–2022)
Hélio S. Sader, John H. Kimbrough, Timothy B Doyle, et al.
Open Forum Infectious Diseases (2025) Vol. 12, Iss. 4
Open Access
Clinical burden of Acinetobacter baumannii, including carbapenem-resistant A. baumannii, in hospitalized adult patients in the USA between 2018 and 2022
Thomas P. Lodise, Sean Nguyen, Caroline Margiotta, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
The Molecular Mouse System: A New Useful Tool for Guiding Antimicrobial Therapy in Critically Ill Septic Patients
Carola Mauri, Alessandra Consonni, Elena Briozzo, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 517-517
Open Access | Times Cited: 3
Multidrug-Resistant Organisms: The Silent Plight of Burn Patients
Randa Elsheikh, Abdelrahman M. Makram
Journal of Burn Care & Research (2024) Vol. 45, Iss. 4, pp. 877-886
Open Access | Times Cited: 2
Predicting early appropriate therapy for patients infected by carbapenem-resistant Gram-negative pathogens in intensive care units in Italy
Matteo Bassetti, Gianpaola Monti, Anne Santerre Henriksen, et al.
Antimicrobial Resistance and Infection Control (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals
John H. Kimbrough, Joshua Maher, Hélio S. Sader, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 2
Trends in Molecular Diagnosis of Nosocomial Pneumonia Classic PCR vs. Point-of-Care PCR: A Narrative Review
Andrei-Mihai Bălan, Constantin Bodolea, Sebastian Trancă, et al.
Healthcare (2023) Vol. 11, Iss. 9, pp. 1345-1345
Open Access | Times Cited: 6
Mortality Due to Multidrug-Resistant Gram-Negative Bacteremia in an Endemic Region: No Better Than a Toss of a Coin
Οlga Tsachouridou, Dimitrios Pilalas, Sideris Nanoudis, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1711-1711
Open Access | Times Cited: 6
Carbapenem-Resistant Gram-Negative Bacilli Characterization in a Tertiary Care Center from El Bajio, Mexico
Nieto-Saucedo José Raúl, Luis Esaú López-Jácome, Rafael Franco‐Cendejas, et al.
Antibiotics (2023) Vol. 12, Iss. 8, pp. 1295-1295
Open Access | Times Cited: 6
Evaluation of the Liquid Colony™ Produced by the FAST System for Shortening the Time of Bacterial Identification and Phenotypic Antimicrobial Susceptibility Testing and Detection of Resistance Mechanisms from Positive Blood Cultures
Chiara Bonaiuto, Ilaria Baccani, Chiara Chilleri, et al.
Diagnostics (2023) Vol. 13, Iss. 11, pp. 1849-1849
Open Access | Times Cited: 5
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
Arsheena Yassin, Mariya Huralska, Jason M. Pogue, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 9, pp. e46-e56
Open Access | Times Cited: 5
Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)
Sofía de la Villa, Carlos Sánchez‐Carrillo, Celia Sánchez-Martínez, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 8, pp. 1948-1954
Open Access | Times Cited: 4
Antimicrobial Stewardship in the Management of Multidrug-Resistant Gram-Negative Bacteria Infections
Temitope O. Oyedemi, Tolulope Elizabeth Fadeyi, Kolapo Fasina
Pharmaceutical science. (2024)
Open Access | Times Cited: 1
Next-Gen Nano Biosensor Technologies to Monitor Carbapenem Resistance for Personalized Medicine
Rahul Harikumar Lathakumari, K.V. Leela, Jayaprakash Thulukanam, et al.
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 1
Evaluation of Quantamatrix dRASTTM system for rapid antimicrobial susceptibility testing of bacterial isolates from positive blood cultures, in comparison with commercial Micronaut broth microdilution system
Fabio Morecchiato, Marco Coppi, Chiara Chilleri, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 110, Iss. 1, pp. 116436-116436
Closed Access | Times Cited: 1
A Whole-Genome Sequencing-Based Approach for the Characterization of Klebsiella pneumoniae Co-Producing KPC and OXA-48-like Carbapenemases Circulating in Sardinia, Italy
Arcadia Del Rio, Valeria Fox, Narcisa Muresu, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2354-2354
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top